Traumatic brain injury biomarkers market to reach $3.68 billion by 2030 at 21.6% CAGR, driven by rising road traffic accidents and growing adoption of personalized medicine.
Read More
Testosterone replacement therapy market to reach $2.57 billion by 2030 at 4.0% CAGR, driven by rising testosterone deficiency among aging men.
Read More
Trastuzumab biosimilars market to reach $24.48 billion by 2030 at 28.9% CAGR, driven by rising prevalence of breast and gastric cancer increasing demand for affordable biologics.
Read More
Testosterone cypionate api market to reach $6.38 billion by 2030 at 10.9% CAGR, driven by growing frequency of hypogonadism and rising geriatric male population.
Read More
Transfection technologies market to reach $1.99 billion by 2030 at 8.7% CAGR, driven by rising adoption of gene therapy and growing need for efficient gene delivery tools.
Read More
Testosterone booster market to reach $7.83 billion by 2030 at 6.3% CAGR, driven by growing awareness about health and fitness among men.
Read More
Transdermal skin patches market to reach $9.57 billion by 2030 at 4.5% CAGR, driven by increasing prevalence of cardiovascular diseases boosting demand for non invasive therapies.
Read More
Tenosynovitis drugs market to reach $1.84 billion by 2030 at 7.6% CAGR, driven by increasing incidence of sports injuries and rising healthcare expenditure.
Read More
Transdermal drug delivery systems market to reach $57.94 billion by 2030 at 7.7% CAGR, driven by rising prevalence of chronic diseases requiring long term and controlled drug administration.
Read More
Tenofovir disoproxil market to reach $4.86 billion by 2030 at 5.3% CAGR, driven by growing prevalence of hepatitis b and rising healthcare expenditure.
Read More